Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Study shows how treatment resistance develops in patients with bile duct cancer

Study shows how treatment resistance develops in patients with bile duct cancer

Eating more vegetables provides no extra protection for men with prostate cancer

Eating more vegetables provides no extra protection for men with prostate cancer

Increased Vegetable Intake Fails to Slow Prostate Cancer Progression, Study Finds

Increased Vegetable Intake Fails to Slow Prostate Cancer Progression, Study Finds

World Trade Center rescue and recovery workers found to have increased leukemia incidence

World Trade Center rescue and recovery workers found to have increased leukemia incidence

Researchers uncover genetic anomaly linked with poor response to common asthma treatment

Researchers uncover genetic anomaly linked with poor response to common asthma treatment

New framework developed to estimate the growth of individual cancer

New framework developed to estimate the growth of individual cancer

Study demonstrates accuracy of AI system in diagnosing prostate cancer

Study demonstrates accuracy of AI system in diagnosing prostate cancer

Common genetic defect in prostate cancer associated with worse prognosis

Common genetic defect in prostate cancer associated with worse prognosis

New AI system determines aggressiveness of prostate cancer better than most pathologists

New AI system determines aggressiveness of prostate cancer better than most pathologists

Administering enzalutamide results in significant increase in PSMA density on tumor surface

Administering enzalutamide results in significant increase in PSMA density on tumor surface

Prostate cancer deaths are on the rise, shows new ACS report

Prostate cancer deaths are on the rise, shows new ACS report

Researchers identify new mechanism associated with p53 mutation

Researchers identify new mechanism associated with p53 mutation

Report highlights steady 26-year decline in overall cancer mortality

Report highlights steady 26-year decline in overall cancer mortality

Patient care could be affected as health research faces a crisis

Patient care could be affected as health research faces a crisis

Phase II case-control trial initiated for four types of terminal cancers

Phase II case-control trial initiated for four types of terminal cancers

National veteran dataset will help dissect the relationship between mental illness and prostate cancer

National veteran dataset will help dissect the relationship between mental illness and prostate cancer

Targeted screening effective in reducing prostate cancer deaths

Targeted screening effective in reducing prostate cancer deaths

Target at-risk patients for prostate cancer screening, say experts

Target at-risk patients for prostate cancer screening, say experts

Parenting your aging parents when they don’t want help

Parenting your aging parents when they don’t want help

A fast, sensitive technique to detect cancer markers brings liquid biopsy closer to clinic

A fast, sensitive technique to detect cancer markers brings liquid biopsy closer to clinic